It is great to see GWP$ be successful with there trials. There success will help the whole sector since there the current leader in this young industry. From what I see, OWCP will be seriously challenging that in 2020 with there phase 1 and 2 trials on there cream and tablet. Also there is probably 12 different patents that will be granted to OWCP by then, and I'm being conservative. GWP$ has close to 40 patents, but one patent that will set OWCP from them 40 is the One patent which the CBO mentioned in his introduction to shareholders on delivery systems that will certainly add value beyond anyone's expectations IMO.

There possibly already done and could be announced. The group was in California before they were ever in Canada.

Gary, if you click on " hot" at the top of your I-hub page you can click on most read boards. Owcp continuously hangs around number 10. So there is more eyes on Owcp then investors IMO. There obviously waiting for Some big news. This is actually a good thing.

https://scienceblog.com/497482/study-finds-medical-cannabis-effective-reducing-opioid-addiction/

I've never heard of this chart, but I'm not a chart guy. You've seen this chart do this before in other companies?

And $4 to $7 after announcements of sales. It's nice of him to point out that other then innovation patent we are still working through the process to get a number of our patents granted. If we are worth .40 cents today imagine when there all or mostly granted. A majority of the major market mover ones were applied for in or around 2015 so there could be quite a few getting granted in the upcoming year!!

I just googled PDAEAIO that stands for Patent, Dr., and Accounting Expert All In One. There is no such thing, Your out:):):):):)!

My investment is not your responsibility.

OWCP & PFIZER...... Owcp never denied the connection, just acknowledged they didn't know the source of that article!

There going to raise capital for there condom that helps with erectile disfunction....... you out of all people should be excited from what I've heard:)

The appointment of Ms. Hannah Feuer now helps me understand better there intentions on how to raise capital to fund there upcoming clinical trials and business activities. The pieces are coming together in this young and upcoming company! The longterm trajectory of this stock pps is up.

Here's an article from the other site. There's one part that caught my attention about filing for IND like OWCP is going to do. Looks like we're heading in the right direction here.

BOL plans to apply for 'investigative new drug' status from the Food and Drug Administration (FDA) next year.
Such an approval would open up a huge market

Read more: http://www.dailymail.co.uk/health/article-5066395/Israel-3rd-biggest-exporter-medical-cannabis.html#ixzz4ySqDJOUl
Follow us: @MailOnline on Twitter | DailyMail on Facebook

Safety study started in October it says in 10q and according to website will be completed q1

You get what you put in... there given shares as a payment to run the show, what else would they get until revenue starts. Call it what you want:)

I don't care what they call it as long as it truly helps people and the pps reflects that:)! Which Rosenbalt stated " POSSIBLE BREAKTHROUGH" so I would say we are on the right path here. They can call it CanaI-Glow psor.

Both phase 2 trials will be complete in around 2019. Then I would assume a phase 3 trial to follow if that proves itself. We will be far along in our clinical studies in time for 2020 election that hopefully definitely will change the direction of mmj in the United States. We would be top on a buyout list if that were to happen due to these trials. I'm prepared to wait that long as this pps will go into uncharted waters, beyond most people's imagination.

Lows must be in, we're building a base from here!

You will get all the links you want when the company believes there IP is fully protected. Until then it's a waiting game.

Ha ha That's what I was thinking too!

Also after realizing there product was a " POSIBLE BREAK THROUGH" according to Rozenbalt, the study was expanded which has obviously had an effect on timelines. There's all your answers, good talk today! This is a real biopharma company, the future is Glowing:)

The efficacy was the 70 percent improvement in biological markers. It was done on tissue not humans. The phase 2 there doing will be done on humans as there website calls out.

What efficacy report due in March you referring to? Provide a link.

The safety study will be complete q1, it says it right after Canapsor if you keep looking. Safety trial doesn't have to be updated.

The research reports according to Rozenblat will be out around now into December.

All this talk if Mediq and Emelia is still with us will be answered in tomorrow's 10q unless it's late. So we will know soon enough.

Yes it will! I just read an article not long ago that the U.S. and its allies are in need of a new drug after the Syria nerve gas attack this spring. It is very possible Intiva could get funding to get this going through orphan drug from a country or multiple countries.

I hope that is the case..... solid investors will stay intact that way:)!

One is promoting the product in the medical field, the other in the cosmetic field. There both needed and still on board to my knowledge.

Longs just got longer, shorts will start taking a small position in the company since the timeline has been identified I would suspect. This is Hirsch regaining shareholder confidence, and owcp science at its finest!

Don't underestimate the value of the fibromyalgia study ongoing! That's a huge market! One study using the tablet and one using the Nasal spray. 2018 looks to be a busy year for OWCP!

Correction in my previous post, there doing a Pre-IND. MULTI BILLION DOLLAR MARKET CAP IN THE FUTURE!

https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/default.htm

Kraken, there doing in IND for selling it as a drug in the states in Q1 2018. I would suspect some substantial news events in more detail regarding these studies in the near future. Longterm, It appears there looking to take the cream and tablets in for FDA approval, thus the phase 2 trials. There getting it done in Isreal instead of the U.S. for pennies on the dollar.

https://en.wikipedia.org/wiki/Investigational_New_Drug

Numbers and proven science don't lie. The more proven studies about mmj the better, no matter what company is doing it. There will come a day when the Gov. will not be able to ignore the science that don't lie and the shear numbers of people that it's helping. That's a real fact that can't be ignored by some of the biggest opposers as these studies prove them selves through documented science.

Also, here's an article regarding the cream and mediq that came out in June when they made the Announcement.

https://psoriasisnewstoday.com/2017/06/01/owcp-and-mediq-collaborate-to-introduce-cannabinoid-based-psoriasis-cream-in-germany/

They announced it was market ready and hired Mediq to start selling the cream in Germany and throughout Europe amongst other places in June. Since then there has been no news as to when sales will start. I would suspect an announcement regarding that before the end of the year with many countries and states going legal in 2018. Revenue announcements to probably follow that. Obviously if you believe my statements to be true and correct, it's better to buy now then when them announcements of sales start trickling in. Also added this summer was a solid CFO and Chairman which confirms the future longterm is solid.

5 years ago if someone told me to buy a Mmj biopharma company stock I would've laughed at them! Why in the world would I buy something that's not proven, and plus if it were proven where the hell would they sell it because it's illegal nearly every where in the world. Fast forward to today and mmj is scientifically being proven and the world in general, mainly starting in 2018 is making it legal. These countries will need and want products like OWCP is developing in the upcoming months and years.

I'm a disiplined investor and always have the philosophy of never buy more then you can afford to loose and always sell on big runs to get your original investment back and ride the rest of your shares to the top if you believe in the future of the company.

Our leadership is now in place, and our products our coming online just in time for the legalization of mmj. Imagine what the pps will be 5 years from now.

That's what I was trying to say, I was just going the long way about it:) the sector in majority and general has been down, that is soon to change. To many countries have made it legal to stop now!

Please provide a link that shows all the OTC mmj companies stock pps on March 1st vs today to determine if indeed one individual makes a difference or if it's a sector wide issue.

. Pre clinical are not tagged with percentage mark, simply because they are done on human tissues and not on human beings, so it's impossible. So let's move off that one, shall we.

I'm going to, the Israeli bunch will be there and plus it's cold as hell where I live that time of year! Ha ha

We are a Diamond sponsor at the Wall Street Conference. I have to wonder since Ziv Turner is gone if Mr. Hirsch will be speaking.

http://wallstconference.com/

I didn't miss the point, I have compared and feel they are one of the best teams out there especially with our Beruch and his experience heading up the Israeli mmj front for many years. I posted there website so you could spend the time looking at the group and comparing to others and coming to your own conclusion.